1	Retinoid	Retinoid	_	_	_	_	_	_	_
2	X	X	_	_	_	_	_	_	_
3	receptor	receptor	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	RXR	RXR	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	agonist-induced	agonist-induced	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	dominant-negative	dominant-negative	_	_	_	_	_	_	_
11	RXR-retinoic	rxr-retinoic	_	_	_	_	_	_	_
12	acid	acid	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	alpha403	alpha403	_	_	_	_	_	_	_
15	heterodimers	heterodimer	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	developmentally	developmentally	_	_	_	_	_	_	_
18	regulated	regulate	_	_	_	_	_	_	_
19	during	during	_	_	_	_	_	_	_
20	myeloid	myeloid	_	_	_	_	_	_	_
21	differentiation	differentiation	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	multiple	multiple	_	_	_	_	_	_	_
3	biologic	biologic	_	_	_	_	_	_	_
4	activities	activity	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	retinoic	retinoic	_	_	_	_	_	_	_
7	acid	acid	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	RA	RA	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	mediated	mediate	_	_	_	_	_	_	_
13	through	through	_	_	_	_	_	_	_
14	RAR	RAR	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	retinoid	retinoid	_	_	_	_	_	_	_
17	X	x	_	_	_	_	_	_	_
18	receptor	receptor	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	RXR	RXR	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	nuclear	nuclear	_	_	_	_	_	_	_
23	receptors	receptor	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	interact	interact	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	specific	specific	_	_	_	_	_	_	_
28	DNA	dna	_	_	_	_	_	_	_
29	target	target	_	_	_	_	_	_	_
30	sequences	sequence	_	_	_	_	_	_	_
31	as	as	_	_	_	_	_	_	_
32	heterodimers	heterodimer	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	RXR-RAR	RXR-RAR	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	or	or	_	_	_	_	_	_	_
37	homodimers	homodimer	_	_	_	_	_	_	_
38	(	(	_	_	_	_	_	_	_
39	RXR-RXR	RXR-RXR	_	_	_	_	_	_	_
40	)	)	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	RA	RA	_	_	_	_	_	_	_
2	receptor	receptor	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	appears	appear	_	_	_	_	_	_	_
5	critical	critical	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	regulating	regulate	_	_	_	_	_	_	_
8	important	important	_	_	_	_	_	_	_
9	aspects	aspect	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	hematopoiesis	hematopoiesis	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	since	since	_	_	_	_	_	_	_
14	transducing	transduce	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	COOH-terminally	cooh-terminally	_	_	_	_	_	_	_
17	truncated	truncate	_	_	_	_	_	_	_
18	RARalpha	RARalpha	_	_	_	_	_	_	_
19	exhibiting	exhibit	_	_	_	_	_	_	_
20	dominant-negative	dominant-negative	_	_	_	_	_	_	_
21	activity	activity	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	RARalpha403	RARalpha403	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	into	into	_	_	_	_	_	_	_
26	normal	normal	_	_	_	_	_	_	_
27	mouse	mouse	_	_	_	_	_	_	_
28	bone	bone	_	_	_	_	_	_	_
29	marrow	marrow	_	_	_	_	_	_	_
30	generates	generate	_	_	_	_	_	_	_
31	hematopoietic	hematopoietic	_	_	_	_	_	_	_
32	growth	growth	_	_	_	_	_	_	_
33	factor-dependent	factor-dependent	_	_	_	_	_	_	_
34	cell	cell	_	_	_	_	_	_	_
35	lines	line	_	_	_	_	_	_	_
36	frozen	freeze	_	_	_	_	_	_	_
37	at	at	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	multipotent	multipotent	_	_	_	_	_	_	_
40	progenitor	progenitor	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	EML	EML	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	or	or	_	_	_	_	_	_	_
45	committed	commit	_	_	_	_	_	_	_
46	promyelocyte	promyelocyte	_	_	_	_	_	_	_
47	(	(	_	_	_	_	_	_	_
48	MPRO	mpro	_	_	_	_	_	_	_
49	)	)	_	_	_	_	_	_	_
50	stages	stage	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	Nevertheless	nevertheless	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	relatively	relatively	_	_	_	_	_	_	_
4	high	high	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	pharmacological	pharmacological	_	_	_	_	_	_	_
7	concentrations	concentration	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	RA	RA	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	1	1	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	10	10	_	_	_	_	_	_	_
14	&	&	_	_	_	_	_	_	_
15	mgr;M	mgr;M	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	overcome	overcome	_	_	_	_	_	_	_
18	these	these	_	_	_	_	_	_	_
19	differentiation	differentiation	_	_	_	_	_	_	_
20	blocks	block	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	induce	induce	_	_	_	_	_	_	_
23	terminal	terminal	_	_	_	_	_	_	_
24	granulocytic	granulocytic	_	_	_	_	_	_	_
25	differentiation	differentiation	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	MPRO	mpro	_	_	_	_	_	_	_
29	promyelocytes	promyelocyte	_	_	_	_	_	_	_
30	while	while	_	_	_	_	_	_	_
31	potentiating	potentiate	_	_	_	_	_	_	_
32	interleukin-3	interleukin-3	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	IL-3)-induced	il-3)-induced	_	_	_	_	_	_	_
35	commitment	commitment	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	EML	EML	_	_	_	_	_	_	_
38	cells	cell	_	_	_	_	_	_	_
39	to	to	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	granulocyte/monocyte	granulocyte/monocyte	_	_	_	_	_	_	_
42	lineage	lineage	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	present	present	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	we	we	_	_	_	_	_	_	_
7	utilized	utilize	_	_	_	_	_	_	_
8	RXR-	rxr-	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	RAR-specific	rar-specific	_	_	_	_	_	_	_
11	agonists	agonist	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	antagonists	antagonist	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	determine	determine	_	_	_	_	_	_	_
16	how	how	_	_	_	_	_	_	_
17	RA	RA	_	_	_	_	_	_	_
18	overcomes	overcome	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	dominant-negative	dominant-negative	_	_	_	_	_	_	_
21	activity	activity	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	truncated	truncate	_	_	_	_	_	_	_
25	RARalpha	RARalpha	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	these	these	_	_	_	_	_	_	_
28	different	different	_	_	_	_	_	_	_
29	myeloid	myeloid	_	_	_	_	_	_	_
30	developmental	developmental	_	_	_	_	_	_	_
31	stages	stage	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Unexpectedly	unexpectedly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	observed	observe	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	RXR-specific	rxr-specific	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	rather	rather	_	_	_	_	_	_	_
10	than	than	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	RAR-specific	rar-specific	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	agonist	agonist	_	_	_	_	_	_	_
15	induces	induce	_	_	_	_	_	_	_
16	terminal	terminal	_	_	_	_	_	_	_
17	granulocytic	granulocytic	_	_	_	_	_	_	_
18	differentiation	differentiation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	MPRO	mpro	_	_	_	_	_	_	_
21	promyelocytes	promyelocyte	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	this	this	_	_	_	_	_	_	_
25	differentiation	differentiation	_	_	_	_	_	_	_
26	is	be	_	_	_	_	_	_	_
27	associated	associate	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	activation	activation	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	DNA	DNA	_	_	_	_	_	_	_
32	response	response	_	_	_	_	_	_	_
33	elements	element	_	_	_	_	_	_	_
34	corresponding	correspond	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	RAR-RXR	rar-rxr	_	_	_	_	_	_	_
37	heterodimers	heterodimer	_	_	_	_	_	_	_
38	rather	rather	_	_	_	_	_	_	_
39	than	than	_	_	_	_	_	_	_
40	RXR-RXR	rxr-rxr	_	_	_	_	_	_	_
41	homodimers	homodimer	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	RXR	RXR	_	_	_	_	_	_	_
3	agonist	agonist	_	_	_	_	_	_	_
4	activity	activity	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	blocked	block	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	RAR-specific	rar-specific	_	_	_	_	_	_	_
9	antagonists	antagonist	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	suggesting	suggest	_	_	_	_	_	_	_
12	extensive	extensive	_	_	_	_	_	_	_
13	cross-talk	cross-talk	_	_	_	_	_	_	_
14	between	between	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	partners	partner	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	RXR	RXR	_	_	_	_	_	_	_
20	-RARalpha403	-raralpha403	_	_	_	_	_	_	_
21	heterodimer	heterodimer	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	more	more	_	_	_	_	_	_	_
7	immature	immature	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	multipotent	multipotent	_	_	_	_	_	_	_
10	EML	EML	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	we	we	_	_	_	_	_	_	_
13	observed	observe	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	this	this	_	_	_	_	_	_	_
16	RXR-specific	rxr-specific	_	_	_	_	_	_	_
17	agonist	agonist	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	inactive	inactive	_	_	_	_	_	_	_
20	either	either	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	potentiating	potentiate	_	_	_	_	_	_	_
23	IL-3-mediated	il-3-mediated	_	_	_	_	_	_	_
24	commitment	commitment	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	EML	EML	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	granulocyte	granulocyte	_	_	_	_	_	_	_
31	lineage	lineage	_	_	_	_	_	_	_
32	or	or	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	transactivating	transactivate	_	_	_	_	_	_	_
35	RAR-RXR	RAR-RXR	_	_	_	_	_	_	_
36	response	response	_	_	_	_	_	_	_
37	elements	element	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	RA-	RA-	_	_	_	_	_	_	_
2	triggered	trigger	_	_	_	_	_	_	_
3	GALdbd-RARalpha	GALdbd-RARalpha	_	_	_	_	_	_	_
4	hybrid	hybrid	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	these	these	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	indicates	indicate	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	multipotent	multipotent	_	_	_	_	_	_	_
13	EML	EML	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	harbor	harbor	_	_	_	_	_	_	_
16	substantial	substantial	_	_	_	_	_	_	_
17	nuclear	nuclear	_	_	_	_	_	_	_
18	hormone	hormone	_	_	_	_	_	_	_
19	receptor	receptor	_	_	_	_	_	_	_
20	coactivator	coactivator	_	_	_	_	_	_	_
21	activity	activity	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	histone	histone	_	_	_	_	_	_	_
5	deacetylase	deacetylase	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	HDAC	HDAC	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	inhibitor	inhibitor	_	_	_	_	_	_	_
10	trichostatin	trichostatin	_	_	_	_	_	_	_
11	A	a	_	_	_	_	_	_	_
12	readily	readily	_	_	_	_	_	_	_
13	activates	activate	_	_	_	_	_	_	_
14	an	an	_	_	_	_	_	_	_
15	RXR-RAR	rxr-rar	_	_	_	_	_	_	_
16	reporter	reporter	_	_	_	_	_	_	_
17	construct	construct	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	multipotent	multipotent	_	_	_	_	_	_	_
21	EML	EML	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	but	but	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	committed	commit	_	_	_	_	_	_	_
28	MPRO	mpro	_	_	_	_	_	_	_
29	promyelocytes	promyelocyte	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	indicating	indicate	_	_	_	_	_	_	_
32	that	that	_	_	_	_	_	_	_
33	differences	difference	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	HDAC-containing	hdac-containing	_	_	_	_	_	_	_
36	repressor	repressor	_	_	_	_	_	_	_
37	complexes	complex	_	_	_	_	_	_	_
38	in	in	_	_	_	_	_	_	_
39	these	these	_	_	_	_	_	_	_
40	two	two	_	_	_	_	_	_	_
41	closely	closely	_	_	_	_	_	_	_
42	related	related	_	_	_	_	_	_	_
43	but	but	_	_	_	_	_	_	_
44	distinct	distinct	_	_	_	_	_	_	_
45	hematopoietic	hematopoietic	_	_	_	_	_	_	_
46	lineages	lineage	_	_	_	_	_	_	_
47	might	might	_	_	_	_	_	_	_
48	account	account	_	_	_	_	_	_	_
49	for	for	_	_	_	_	_	_	_
50	the	the	_	_	_	_	_	_	_
51	differential	differential	_	_	_	_	_	_	_
52	activation	activation	_	_	_	_	_	_	_
53	of	of	_	_	_	_	_	_	_
54	the	the	_	_	_	_	_	_	_
55	RXR-RARalpha403	rxr-raralpha403	_	_	_	_	_	_	_
56	heterodimers	heterodimer	_	_	_	_	_	_	_
57	that	that	_	_	_	_	_	_	_
58	we	we	_	_	_	_	_	_	_
59	observed	observe	_	_	_	_	_	_	_
60	at	at	_	_	_	_	_	_	_
61	these	these	_	_	_	_	_	_	_
62	different	different	_	_	_	_	_	_	_
63	stages	stage	_	_	_	_	_	_	_
64	of	of	_	_	_	_	_	_	_
65	myeloid	myeloid	_	_	_	_	_	_	_
66	development	development	_	_	_	_	_	_	_
67	.	.	_	_	_	_	_	_	_

